|
1
|
Anders CK and Carey LA: Biology,
metastatic patterns, and treatment of patients with triple-negative
breast cancer. Clin Breast Cancer. 9 Suppl 2:S73–S81. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haffty BG, Yang Q, Reiss M, Kearney T,
Higgins SA, Weidhaas J, Harris L, Hait W and Toppmeyer D:
Locoregional relapse and distant metastasis in conservatively
managed triple negative early-stage breast cancer. J Clin Oncol.
24:5652–5657. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Palma G, Frasci G, Chirico A, Esposito E,
Siani C, Saturnino C, Arra C, Ciliberto G, Giordano A and D'Aiuto
M: Triple negative breast cancer: Looking for the missing link
between biology and treatments. Oncotarget. 6:26560–26574. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shindikar A, Singh A, Nobre M and
Kirolikar S: Curcumin and resveratrol as promising natural remedies
with nanomedicine approach for the effective treatment of triple
negative breast cancer. J Oncol. 2016:97507852016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jamdade VS, Sethi N, Mundhe NA, Kumar P,
Lahkar M and Sinha N: Therapeutic targets of triple-negative breast
cancer: A review. Br J Pharmacol. 172:4228–4237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun XD, Liu XE and Huang DS: Curcumin
induces apoptosis of triple-negative breast cancer cells by
inhibition of EGFR expression. Mol Med Rep. 6:1267–1270. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jung KH, Lee JH, Park JW, Moon SH, Cho YS
and Lee KH: Effects of curcumin on cancer cell mitochondrial
function and potential monitoring with 18F-FDG uptake.
Oncol Rep. 35:861–868. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anand P, Kunnumakkara AB, Newman RA and
Aggarwal BB: Bioavailability of curcumin: Problems and promises.
Mol Pharm. 4:807–818. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yallapu MM, Jaggi M and Chauhan SC:
Curcumin nanoformulations: A future nanomedicine for cancer. Drug
Discov Today. 17:71–80. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung KH, Lee JH, Park JW, Quach CHT, Moon
SH, Cho YS and Lee KH: Resveratrol-loaded polymeric nanoparticles
suppress glucose metabolism and tumor growth in vitro and in vivo.
Int J Pharm. 478:251–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naksuriya O, Okonogi S, Schiffelers RM and
Hennink WE: Curcumin nanoformulations: A review of pharmaceutical
properties and preclinical studies and clinical data related to
cancer treatment. Biomaterials. 35:3365–3383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng J, Teply BA, Sherifi I, Sung J,
Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R and
Farokhzad OC: Formulation of functionalized PLGA-PEG nanoparticles
for in vivo targeted drug delivery. Biomaterials. 28:869–876. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan JM, Zhang L, Yuet KP, Liao G, Rhee
JW, Langer R and Farokhzad OC: PLGA-lecithin-PEG core-shell
nanoparticles for controlled drug delivery. Biomaterials.
30:1627–1634. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wong C, Stylianopoulos T, Cui J, Martin J,
Chauhan VP, Jiang W, Popovic Z, Jain RK, Bawendi MG and Fukumura D:
Multistage nanoparticle delivery system for deep penetration into
tumor tissue. Proc Natl Acad Sci USA. 108:2426–2431. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baselga J and Arteaga CL: Critical update
and emerging trends in epidermal growth factor receptor targeting
in cancer. J Clin Oncol. 23:2445–2459. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masuda H, Zhang D, Bartholomeusz C,
Doihara H, Hortobagyi GN and Ueno NT: Role of epidermal growth
factor receptor in breast cancer. Breast Cancer Res Treat.
136:331–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jung KH, Choe YS, Paik JY and Lee KH:
99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene
glycol-quantum dot imaging allows quantification of breast cancer
epidermal growth factor receptor expression and monitors receptor
downregulation in response to cetuximab therapy. J Nucl Med.
52:1457–1464. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jung KH, Park JW, Paik JY, Quach CH, Choe
YS and Lee KH: EGF receptor targeted tumor imaging with
biotin-PEG-EGF linked to (99m)Tc-HYNIC labeled avidin and
streptavidin. Nucl Med Biol. 39:1122–1127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Chen L, Liu N, Li S, Hao Y and Zhang
X: EGF-coated nano-dendriplexes for tumor-targeted nucleic acid
delivery in vivo. Drug Deliv. 23:1718–1725. 2016.PubMed/NCBI
|
|
20
|
Yan J, Wang Y, Jia Y, Liu S, Tian C, Pan
W, Liu X and Wang H: Co-delivery of docetaxel and curcumin prodrug
via dual-targeted nanoparticles with synergistic antitumor activity
against prostate cancer. Biomed Pharmacother. 88:374–383. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao BJ, Ke XY, Huang Y, Chen XM, Zhao X,
Zhao BX, Lu WL, Lou JN, Zhang X and Zhang Q: The antiangiogenic
efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel
(NGR-M-PTX) for the treatment of glioma in rats. J Drug Target.
19:382–390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weingart J, Vabbilisetty P and Sun XL:
Membrane mimetic surface functionalization of nanoparticles:
Methods and applications. Adv Colloid Interface Sci. 197–198:68–84.
2013. View Article : Google Scholar
|
|
23
|
Pandey RK and Prajapati VK: Molecular and
immunological toxic effects of nanoparticles. Int J Biol Macromol.
107:1278–1293. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gothwal A, Khan I and Gupta U: Polymeric
micelles: Recent advancements in the delivery of anticancer drugs.
Pharm Res. 33:18–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gülçür E, Thaqi M, Khaja F, Kuzmis A and
Önyüksel H: Curcumin in VIP-targeted sterically stabilized
phospholipid nanomicelles: A novel therapeutic approach for breast
cancer and breast cancer stem cells. Drug Deliv Transl Res. 3:2013.
View Article : Google Scholar
|
|
26
|
Perrault SD, Walkey C, Jennings T, Fischer
HC and Chan WC: Mediating tumor targeting efficiency of
nanoparticles through design. Nano Lett. 9:1909–1915. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kunwar A, Barik A, Mishra B, Rathinasamy
K, Pandey R and Priyadarsini KI: Quantitative cellular uptake,
localization and cytotoxicity of curcumin in normal and tumor
cells. Biochim Biophys Acta. 1780:673–679. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Strojny B, Grodzik M, Sawosz E, Winnicka
A, Kurantowicz N, Jaworski S, Kutwin M, Urbańska K, Hotowy A,
Wierzbicki M and Chwalibog A: Diamond nanoparticles modify curcumin
activity: In vitro studies on cancer and normal cells and in ovo
studies on chicken embryo model. PLoS One. 11:e01646372016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yallapu MM, Jaggi M and Chauhan SC:
Curcumin nanomedicine: A road to cancer therapeutics. Curr Pharm
Des. 19:1994–2010. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deguchi A: Curcumin targets in
inflammation and cancer. Endocr Metab Immune Disord Drug Targets.
15:88–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shanmugam MK, Rane G, Kanchi MM, Arfuso F,
Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP and Sethi G:
The multifaceted role of curcumin in cancer prevention and
treatment. Molecules. 20:2728–2769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Taurin S, Nehoff H, Diong J, Larsen L,
Rosengren RJ and Greish K: Curcumin-derivative nanomicelles for the
treatment of triple negative breast cancer. J Drug Target.
21:675–683. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jung C, Kaul MG, Bruns OT, Dučić T, Freund
B, Heine M, Reimer R, Meents A, Salmen SC, Weller H, et al:
Intraperitoneal injection improves the uptake of
nanoparticle-labeled high-density lipoprotein to atherosclerotic
plaques compared with intravenous injection: a multimodal imaging
study in ApoE knockout mice. Circ Cardiovasc Imaging. 7:303–311.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu Y, Zhang X and Qiu L: The anti-tumor
efficacy of curcumin when delivered by size/charge-changing
multistage polymeric micelles based on amphiphilic poly(β-amino
ester) derivates. Biomaterials. 35:3467–3479. 2014. View Article : Google Scholar : PubMed/NCBI
|
